Company History

We present fundamental solutions for intractable neurological diseases through innovative iPSC technology.

  • ABOUT US
  • Company History

This is the record of iPS Bio’s path
to lead the world through
innovation and passion.

2019
Established
2020-2023
Growing
2024-Present
New Horizons
2019
Established
2019
Jul

Company established

2020-2023
Growing
2020
Mar

Approved as a Venture Business

Apr

Corporate Institute accreditation

Jun

Awarded TIPS grant

Jul

Awarded BIG3 grant

2021
Jan

Awarded IPK Bio-Core Facility grant

Mar

Secured Series A funding (8 Billion KRW)

Selected for Excellent Technology Evaluation Company

Nov

Awarded from the Minister of Health and Welfare for
commercialization of health industry technology

2022
Jan

Selected for BIG3 Innovative Start-Up Package

Apr

Awarded Korean Fund for Regenerative Medicine grant
(Huntington's disease)

Jun

Awarded BIG3 grant (Market Expansion) 

2023
Dec

Awarded Regenerative Medicine Clinical Research Infrastructure
Development grant

2024-Present
New Horizons
2024
Jan

Awarded Health and Medical Technology R&D Program:
Establishment of Infrastructure for Clinical Research in
Regenerative Medicine

Mar

Relocated to New Headquarters

Apr

Awarded Korean Fund for  Regenerative Medicine grant (Stroke)

Awarded Research and Development Project Funded by the
Ministry of Food and Drug Safety

Jun

Recognized for New Excellent Technology (NET) for Health

Aug

Awarded Global Innovation Zone Overseas Demonstration grant
(Non-R&D)

Awarded Post-TIPS grant

Sep

Awarded Global Innovation Zone Overseas Demonstration grant
(R&D)